{
    "2018-09-25": [
        [
            {
                "time": "",
                "original_text": "光大证券：长春高新买入评级",
                "features": {
                    "keywords": [
                        "光大证券",
                        "长春高新",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "13股获券商买入评级 常宝股份目标涨幅达61.59%",
                "features": {
                    "keywords": [
                        "常宝股份",
                        "买入评级",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【长春高新】公告点评：迈出国际合作重要一步，提升公司生物药竞争力",
                "features": {
                    "keywords": [
                        "长春高新",
                        "国际合作",
                        "生物药",
                        "竞争力"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周观点:《关于完善国家基本药物制度的意见》出台,关注一致性评价结合基药目录调整带来的新格局",
                "features": {
                    "keywords": [
                        "医药行业",
                        "基本药物制度",
                        "一致性评价",
                        "基药目录"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}